| scholarly article | Q13442814 |
| P50 | author | Tristan Bourcier | Q114532952 |
| P2093 | author name string | Julie Brunet | |
| Ermanno Candolfi | |||
| Luc Marcellin | |||
| Alexander W Pfaff | |||
| Marcela Sabou | |||
| Élise Rochet | |||
| P2860 | cites work | Experimental ocular toxoplasmosis in genetically susceptible and resistant mice | Q33946644 |
| Signaling by IL-31 and functional consequences | Q34222387 | ||
| Ocular toxoplasmosis: clinical features and prognosis of 154 patients. | Q34621920 | ||
| Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels | Q35054186 | ||
| A critical role for SOCS3 in innate resistance to Toxoplasma gondii | Q35222475 | ||
| Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice | Q35549575 | ||
| SOCS3, a Major Regulator of Infection and Inflammation. | Q37592325 | ||
| Therapy for ocular toxoplasmosis--the future | Q38101597 | ||
| New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis. | Q38160626 | ||
| Therapeutic uses of anti-interleukin-6 receptor antibody | Q38241714 | ||
| Ocular toxoplasmosis in immunosuppressed nonhuman primates. | Q41437158 | ||
| Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis | Q41597144 | ||
| The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice | Q41770530 | ||
| Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study | Q41883610 | ||
| CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1 | Q42577315 | ||
| Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis | Q44498184 | ||
| Quality of life assessment in ocular toxoplasmosis in a Colombian population | Q44565206 | ||
| Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis | Q44995831 | ||
| Interferon-gamma: the major mediator of resistance against Toxoplasma gondii | Q45128276 | ||
| Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. | Q46022470 | ||
| The local immune response to intraocular Toxoplasma re-challenge: less pathology and better parasite control through Treg/Th1/Th2 induction | Q46437550 | ||
| Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma | Q48164076 | ||
| Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis | Q48459046 | ||
| Neuronal gp130 expression is crucial to prevent neuronal loss, hyperinflammation, and lethal course of murine Toxoplasma encephalitis | Q48491580 | ||
| Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection. | Q51739053 | ||
| Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrences of Toxoplasma Gondii Retinochoroiditis: Randomized Controlled Clinical Trial | Q56792525 | ||
| Tissue cyst rupture in mice chronically infected withToxoplasma gondii | Q61703963 | ||
| Studies on experimental oclar toxoplasmosis in the rabbit. 3. Recurrent inflammation stimulated by systemic administration of antilymphocyte serum and normal horse serum | Q71802679 | ||
| Role of gamma interferon and T cells in congenital Toxoplasma transmission | Q81337734 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toxoplasmosis | Q154878 |
| P304 | page(s) | 2109-2117 | |
| P577 | publication date | 2015-03-09 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Interleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation | |
| P478 | volume | 83 |
| Q40166381 | CCR5 Is Involved in Interruption of Pregnancy in Mice Infected with Toxoplasma gondii during Early Pregnancy |
| Q58606385 | Differences in Ocular Complications Between and Non-albicans Infection Analyzed by Epidemiology and a Mouse Ocular Candidiasis Model |
| Q36377328 | Experimental Models of Ocular Infection with Toxoplasma Gondii |
| Q64956005 | Extracellular Vesicles Secreted by Neospora caninum Are Recognized by Toll-Like Receptor 2 and Modulate Host Cell Innate Immunity Through the MAPK Signaling Pathway. |
| Q40302723 | Galectins expressed differently in genetically susceptible C57BL/6 and resistant BALB/c mice during acute ocular Toxoplasma gondii infection |
| Q92404834 | IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases |
| Q64235477 | Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis |
| Q33827284 | Rapid monocyte infiltration following retinal detachment is dependent on non-canonical IL6 signaling through gp130. |
| Q36612019 | The broad-spectrum chemokine inhibitor NR58-3.14.3 modulates macrophage-mediated inflammation in the diseased retina. |
| Q40060207 | Toxoplasma gondii seroprevalence varies by cat breed |
| Q64063550 | Type I ROP16 regulates retinal inflammatory responses during ocular toxoplasmosis |
Search more.